PHARMACY PRACTICE MODULE
PHARMACY PRACTICE-III
Third year
Lecturers: A. Serracino Inglott, L.M. Azzopardi
Lecture
No.
Lecture Title
1
24/10/11
2
24/10/11
3
31/10/11
4
31/10/11
5
7/11/11
6
7/11/11
07/10/2011 LA
PHR-3106
8 credits
Lecture Schedule
Description
Observational methods
Surveys
Questionnaire construction
Data preparation and analysis
Schizophrenia, which is a chronic,
Schizophrenia
debilitating illness where the goal of
treatment is to control psychotic
symptoms, is discussed. A
comparative approach to antipyschotic
medications is adopted.
Pharmacists are in a position to fill the
Pharmacists’ care plans pharmaceutical care gap that occurs in
and Pharmacist
the practical setting whereby there is
Prescribing
lack of optimal amount of therapeutic
planning. A general introduction to the
planning phase and the development
of disease specific drug treatment
protocols is presented so as to serve
as a basis for disease-oriented
discussions in these credits. An
introduction to the concept of
pharmacist prescribing is presented.
The pharmacists interventions during
Cardiovascular disorders the diagnostic and treatment phases
are aimed to help patients achieve the
desired outcomes of therapy. Clinical
assessment and parameters that
should be monitored in cardiovascular
disease are discussed.
Depression is an affective disorder
Mood disorders
where patient presents with varying
degrees of low mood. Drug treatment
is the mainstay of treatment in
moderate to severe depression but for
treatment to be successful it should be
supported by non-pharmacologic
strategies. Management of acute and
major depression is discussed.
The management of hypertension,
Hypertension
which is considered a major risk factor
for cardiovascular and cerebrovascular
disease, is discussed. Review of
causes of lack of responsiveness to
antihypertensive therapy and of
considerations for individualizing drug
therapy due to co-existing disease
states.
Lecturer
LA
Research
methodology-III
LA
ASI
ASI
LA
ASI
1
7
14/11/11
8
14/11/11
9
21/11/11
10
21/11/11
11
28/11/11
12
28/11/11
13
12/12/11
14
12/12/11
15
19/12/11
16
19/12/11
17
9/01/12
07/10/2011 LA
The management of hypertension,
which is considered a major risk factor
for cardiovascular and
cerebrovascular disease, is discussed.
Review of causes of lack of
responsiveness to antihypertensive
therapy and of considerations for
individualizing drug therapy due to coexisting disease states.
Depression is an affective disorder
Mood disorders II
where patient presents with varying
degrees of low mood. Drug treatment
is the mainstay of treatment in
moderate to severe depression but for
treatment to be successful it should be
supported by non-pharmacologic
strategies. Management of acute and
major depression is discussed.
A condition where there is impairment
Ischaemic heart disease in the supply of oxygenated blood to
cardiac tissue. Treatment of risk
factors is discussed and patient
education necessary is emphasised.
Diagnostic criteria to differentiate
Anxiety disorders
generalized anxiety disorder from the
normal response to stress are
reviewed. The use of antidepressants
and benzodiazepines in the treatment
of anxiety disorder is discussed.
The goal of therapy in cardiac failure is
Congestive heart failure to control symptoms of heart failure.
Medications used to treat heart failure
with special reference to common
management mistakes are discussed.
Difficulties in falling asleep or staying
Sleep disorders
asleep or lack of refreshment from
sleep are common complaints. The
rational use of hypnotic drugs and the
counselling that should be undertaken
on proper sleep hygiene are
discussed.
When hyperlipidaemia is uncontrolled
Hyperlipidaemia
by diet and lifestyle modifications
alone, drug therapy is considered.
Review of drug therapy, risk of side
effects and medication expenses and
dietary compliance.
Eating disorders are discussed with
Eating disorders
special reference to anorexia nervosa
and bulimia.
Management of thrombosis with
Thrombosis
particular reference to patient
education.
Antihistamine drugs and Comparative approach to
allergic rhinitis
antihistamine drugs used for allergic
rhinitis and the common cold.
Skin Disorders
Management of skin allergies, acne
Hypertension II
ASI
LA
ASI
LA
ASI
LA
ASI
LA
ASI
LA
ASI
2
18
9/01/12
19
16/01/12
20
16/01/12
21
13/02/12
and psoriasis is reviewed.
Use of drugs for urinary retention,
Genito-urinary disorders urinary incontinence and urological
pain is reviewed.
Review of adrenergic drugs,
Dispensing of
cholinergic and cholinergic blocking
adrenergic and
drugs; their indications, side effects to
cholinergic drugs
be expected and patient counselling.
Menopause and
Hormone replacement
therapy (HRT)
Dementia and
Alzheimer’s disease
22
13/02/12
Menstrual cycle
disorders and
contraception
20/02/12
Risks and use of
medicines
20/02/12
Quality standards in
pharmacy practice
23
24
25
27/02/12
Hepatitis infection
26
27/02/12
HIV infection
5-9/03/12
12/03/12
26 March
–18 May
07/10/2011 LA
Pharmacy Symposium
Discussion
Practical attachments
Menopause is associated with
problems resulting from the ensuing
loss of oestrogen in the body. HRT is
discussed considering advantages
offered, pharmaceutical dosage forms
available and patient education.
Treatment options in particular
innovative disease-specific therapy
are discussed. Measurement of
patients’ quality of life and of the
decline in cognitive symptoms will be
presented as pharmacotherapy
outcome measurements.
Occurrence of menstrual cycle
disorders and treatment options is
discussed. Oral contraception with
emphasis on patient counselling and
on the various preparations available
is discussed.
Medication errors are a cause of
concern and require establishment of
controlled drug distribution systems
and comprehensive pharmacy
services. Methods and issues
considered in addressing this issue
are discussed.
The concept of evaluation of
professional services provided by the
pharmacist is presented. Methods
adopted to evaluate quality of
professional services provided are
reviewed. Audit exercises and
validation tools are discussed.
The management of viral infectious
diseases will be discussed taking as
an example Hepatitis infection.
Various treatment modalities are
presented.
The treatment regimens used in the
management of HIV infected patients
are discussed. Pharmacist
interventions in this speciality are
presented.
LA
ASI
LA
ASI
LA
ASI
LA
ASI
LA
ASI/LA
ASI/LA
3